Barbara Visentin

785 total citations
9 papers, 646 citations indexed

About

Barbara Visentin is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Barbara Visentin has authored 9 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Immunology. Recurrent topics in Barbara Visentin's work include Sphingolipid Metabolism and Signaling (4 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Cell death mechanisms and regulation (2 papers). Barbara Visentin is often cited by papers focused on Sphingolipid Metabolism and Signaling (4 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Cell death mechanisms and regulation (2 papers). Barbara Visentin collaborates with scholars based in United States, United Kingdom and Italy. Barbara Visentin's co-authors include Roger A. Sabbadini, Kelli Moreno, John Vekich, Rosalía Matteo, Amy L. Cavalli, Shuangxing Yu, Hassan Hall, Vikas Kundra, Yiling Lu and Gordon B. Mills and has published in prestigious journals such as Cancer Cell, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Barbara Visentin

9 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Visentin United States 7 550 260 81 71 65 9 646
Kelli Moreno United States 8 764 1.4× 359 1.4× 105 1.3× 77 1.1× 86 1.3× 9 891
Satish Kalari United States 10 505 0.9× 121 0.5× 105 1.3× 83 1.2× 89 1.4× 13 635
Aki Mikami United States 9 455 0.8× 126 0.5× 108 1.3× 68 1.0× 88 1.4× 11 633
Amy L. Cavalli United States 6 572 1.0× 285 1.1× 72 0.9× 46 0.6× 73 1.1× 6 639
Nevin M. Perera United Kingdom 10 613 1.1× 95 0.4× 72 0.9× 69 1.0× 59 0.9× 11 718
Joshua J. Oaks United States 9 710 1.3× 129 0.5× 90 1.1× 72 1.0× 78 1.2× 19 876
Wade E. Huber United States 5 467 0.8× 299 1.1× 138 1.7× 97 1.4× 36 0.6× 6 710
Ward Sents Belgium 9 531 1.0× 107 0.4× 41 0.5× 63 0.9× 68 1.0× 12 720
Giulia Santinon Italy 6 471 0.9× 446 1.7× 47 0.6× 163 2.3× 62 1.0× 6 829
Yongli Dong China 11 319 0.6× 224 0.9× 111 1.4× 64 0.9× 27 0.4× 19 550

Countries citing papers authored by Barbara Visentin

Since Specialization
Citations

This map shows the geographic impact of Barbara Visentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Visentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Visentin more than expected).

Fields of papers citing papers by Barbara Visentin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Visentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Visentin. The network helps show where Barbara Visentin may publish in the future.

Co-authorship network of co-authors of Barbara Visentin

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Visentin. A scholar is included among the top collaborators of Barbara Visentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Visentin. Barbara Visentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Reynolds, Gary, Barbara Visentin, & Roger A. Sabbadini. (2017). Immunohistochemical Detection of Sphingosine-1-Phosphate and Sphingosine Kinase-1 in Human Tissue Samples and Cell Lines. Methods in molecular biology. 1697. 43–56. 6 indexed citations
2.
Knapik, S, et al.. (2017). High-affinity pan-specific monoclonal antibodies that target cysteinyl leukotrienes and show efficacy in an acute model of colitis. Journal of Lipid Research. 58(7). 1386–1398. 4 indexed citations
3.
Tsuji, Shingo, Bryan Hancock, Barbara Visentin, et al.. (2016). Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer. Molecular Therapy — Oncolytics. 3. 16004–16004. 21 indexed citations
4.
Wang, Xiaoen, Andrea J. Bullock, Marcella Callea, et al.. (2015). Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer. Clinical Cancer Research. 21(8). 1925–1934. 67 indexed citations
5.
Visentin, Barbara, Gary Reynolds, & Roger A. Sabbadini. (2012). Immunohistochemical Detection of Sphingosine-1-Phosphate and Sphingosine Kinase-1 in Human Tissue Samples. Methods in molecular biology. 874. 55–67. 3 indexed citations
6.
Williams, David G., Kelli Moreno, Barbara Visentin, et al.. (2009). Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies. Journal of Lipid Research. 50(11). 2245–2257. 96 indexed citations
7.
Visentin, Barbara, John Vekich, Amy L. Cavalli, et al.. (2006). Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell. 9(3). 225–238. 378 indexed citations
8.
Trevisi, Lucia, et al.. (2004). Antiapoptotic effect of ouabain on human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications. 321(3). 716–721. 44 indexed citations
9.
Vinci, Maria Cristina, et al.. (2003). Effect of vascular endothelial growth factor and epidermal growth factor on iatrogenic apoptosis in human endothelial cells. Biochemical Pharmacology. 67(2). 277–284. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelli Moreno Breakdown of academic impact, for papers by Satish Kalari Breakdown of academic impact, for papers by Aki Mikami Breakdown of academic impact, for papers by Amy L. Cavalli Breakdown of academic impact, for papers by Nevin M. Perera Breakdown of academic impact, for papers by Joshua J. Oaks Breakdown of academic impact, for papers by Wade E. Huber Breakdown of academic impact, for papers by Ward Sents Breakdown of academic impact, for papers by Giulia Santinon Breakdown of academic impact, for papers by Yongli Dong
Rankless by CCL
2026